Want to see IN:BIOFILCHEM full AI Analyst Report?
Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) Financial Statements
Biofil Chemicals & Pharmaceuticals Ltd. Financial Overview
Biofil Chemicals & Pharmaceuticals Ltd.'s market cap is currently $471.94M. The company's EPS TTM is $0.30; its P/E ratio is 96.99; Biofil Chemicals & Pharmaceuticals Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 283.95M | $ 334.02M | $ 400.35M | $ 300.35M | $ 223.82M |
| Gross Profit | $ 10.37M | $ 20.91M | $ 25.28M | $ 25.63M | $ 28.66M |
| Operating Income | $ 3.77M | $ 4.68M | $ 4.17M | $ 7.39M | $ 9.05M |
| EBITDA | $ 37.32M | $ 11.53M | $ 13.06M | $ 12.65M | $ 14.83M |
| Net Income | $ 27.86M | $ 5.58M | $ 7.09M | $ 5.60M | $ 6.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 33.26M | $ 2.55M | $ 22.84M | $ 377.00K | $ 1.45M |
| Total Assets | $ 428.48M | $ 509.60M | $ 470.83M | $ 314.06M | $ 187.32M |
| Total Debt | $ 30.20M | $ 4.71M | $ 4.39M | $ 5.22M | $ 4.65M |
| Net Debt | $ -3.06M | $ 3.39M | $ -18.45M | $ 4.85M | $ 3.20M |
| Total Liabilities | $ 212.84M | $ 321.79M | $ 288.80M | $ 141.04M | $ 18.95M |
| Stockholders' Equity | $ 215.64M | $ 187.82M | $ 182.03M | $ 173.01M | $ 168.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.15M | $ -20.24M | $ 23.71M | $ -1.22M | $ -2.90M |
| Operating Cash Flow | $ -6.15M | $ -19.24M | $ 23.94M | $ -1.12M | $ -2.20M |
| Investing Cash Flow | $ 11.37M | $ -1.00M | $ -229.00K | $ -106.00K | $ -699.00K |
| Financing Cash Flow | $ 25.49M | $ -45.00K | $ -1.25M | $ 151.00K | $ -58.00K |
Currency in INR